In 2022, the U.S. was the leading destination for finished drug products exported from South Korea, with an export value of around 813.8 million U.S. dollars. This was followed by Germany and Turkey. The U.S. was also the leading country among all
Leading destinations for finished drug products exported from South Korea in 2022, by export value (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Italy: pharmaceutical marketing channels according to GPs
- Premium Statistic Italy: pharmaceutical marketing channels according to Medical Specialists 2017
- Premium Statistic Italy: market share of OTC products 2017, by segment
- Premium Statistic Italy: market share of respiratory diseases supplements 2017, by pathology
- Premium Statistic Sales volume of the pharmaceutical market in Italy 2014-2022, by product
- Premium Statistic Market value of prescription drugs in Italy 2001-2022
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Gross pharmaceutical expenditure by the Italian NHS on prescription drugs 2012-2022
- Premium Statistic Net pharmaceutical expenditure by the Italian NHS on prescription drugs 2012-2022
- Premium Statistic Pharmaceutical export value from Brazil 2022, by destination
About the region
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Premium Statistic Revenue of the pharmaceutical company Bracco 2020, by geographical area
- Premium Statistic Foreign-to-Canadian generic drug price ratios by OECD country as of 2018
- Premium Statistic Count of first-time medtech approvals granted by FDA 2006-2017
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2022
- Basic Statistic Allocation of R&D investments in pharmaceutical industry by function 2021
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Basic Statistic Net income of Bausch Health 2011-2023
Selected statistics
7
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Basic Statistic Cumulative price change of orphan drugs in the U.S. 2012-2014
- Premium Statistic Pharmaceutical production value in Mexico 2021, by segment
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Brazil: Hypera Pharma net revenue 2017, by category
- Premium Statistic Value of pharmaceutical product exports in Australia 2008-2019
- Premium Statistic Export value of pharmaceuticals from Finland 2013-2022
- Basic Statistic Visited pharmacy websites during the coronavirus lockdown in Spain January to March
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Premium Statistic Cetilar market share out of the topical analgesic market value 2015-2022
Related statistics
10
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic R&D spending ratio of JW Pharmaceutical South Korea 2014-2022
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
Further related statistics
10
- Sales of Johnson & Johnson 2006-2023 by region
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Celgene's revenue and net income 2006-2018
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- U.S. branded prescription revenue forecast 2009-2015
Further Content: You might find this interesting as well
Statistics
- Sales of Johnson & Johnson 2006-2023 by region
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Celgene's revenue and net income 2006-2018
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- U.S. branded prescription revenue forecast 2009-2015
MFDS (South Korea). (December 28, 2023). Leading destinations for finished drug products exported from South Korea in 2022, by export value (in million U.S. dollars) [Graph]. In Statista. Retrieved April 23, 2024, from https://www.statista.com/statistics/1296858/south-korea-leading-countries-for-finished-drug-exports-by-value/
MFDS (South Korea). "Leading destinations for finished drug products exported from South Korea in 2022, by export value (in million U.S. dollars)." Chart. December 28, 2023. Statista. Accessed April 23, 2024. https://www.statista.com/statistics/1296858/south-korea-leading-countries-for-finished-drug-exports-by-value/
MFDS (South Korea). (2023). Leading destinations for finished drug products exported from South Korea in 2022, by export value (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 23, 2024. https://www.statista.com/statistics/1296858/south-korea-leading-countries-for-finished-drug-exports-by-value/
MFDS (South Korea). "Leading Destinations for Finished Drug Products Exported from South Korea in 2022, by Export Value (in Million U.S. Dollars)." Statista, Statista Inc., 28 Dec 2023, https://www.statista.com/statistics/1296858/south-korea-leading-countries-for-finished-drug-exports-by-value/
MFDS (South Korea), Leading destinations for finished drug products exported from South Korea in 2022, by export value (in million U.S. dollars) Statista, https://www.statista.com/statistics/1296858/south-korea-leading-countries-for-finished-drug-exports-by-value/ (last visited April 23, 2024)
Leading destinations for finished drug products exported from South Korea in 2022, by export value (in million U.S. dollars) [Graph], MFDS (South Korea), December 28, 2023. [Online]. Available: https://www.statista.com/statistics/1296858/south-korea-leading-countries-for-finished-drug-exports-by-value/